Executive Intelligence

Coleman Stavish

Founder

Coleman Stavish is listed as a founder of Proscia based in United States on Brel Digital’s verified company intelligence record.

In this profile

Quick Facts

  • Role Founder
  • Company Proscia
  • Country United States
  • Industry AI in Healthcare
  • Founded 2014
  • Known For Proscia argues pathology AI should be woven into the platform layer — not bolted onto legacy…
  • Status Active
  • Last Reviewed Jul 2026

Executive Summary

Coleman Stavish appears in Brel Digital’s verified company_founders attribution for Proscia based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted. Company context (from the verified Proscia profile): Philadelphia digital pathology platform company embedding AI-native intelligence in Concentriq for labs and life sciences Why the company matters (verified company field): Proscia argues pathology AI should be woven into the platform layer — not bolted onto legacy digital slide viewers — and its Fifth Generation Concentriq launch is a concrete 2026 product bet that enterprise pathology software becomes the intelligence substrate for precision medicine. Official company website on file: https://proscia.com. Readers should consult that site and the Sources section for primary evidence. Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2014 Company founded

    Proscia was founded in 2014 per the company profile source on file.

    Source
  2. 2014 Development

    2014: Proscia founded in Philadelphia by David West, Coleman Stavish, and Nathan Buchbinder.

    Source
  3. 2025 Partnership

    March 19, 2025: Proscia raised $50M led by Insight Partners to advance Concentriq AI capabilities.

    Source
  4. 2026 Product

    June 17, 2026: Proscia launched Fifth Generation of Concentriq with AI-native architecture.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

Coleman Stavish appears in Brel Digital’s verified company_founders attribution for Proscia based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.

Company context (from the verified Proscia profile): Philadelphia digital pathology platform company embedding AI-native intelligence in Concentriq for labs and life sciences

Why the company matters (verified company field): Proscia argues pathology AI should be woven into the platform layer — not bolted onto legacy digital slide viewers — and its Fifth Generation Concentriq launch is a concrete 2026 product bet that enterprise pathology software becomes the intelligence substrate for precision medicine.

Official company website on file: https://proscia.com. Readers should consult that site and the Sources section for primary evidence.

Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

The AI Brief

Founder and company intelligence, weekly.

Subscribe